Tissue repair + immune modulation.
The combination of BPC-157 and Thymosin Alpha-1 represents a multi-pathway approach to biological age reduction. By simultaneously targeting distinct hallmarks of aging, this protocol achieves results that exceed the sum of its individual components.
BPC-157 primarily acts via upregulates vegfr2 to promote angiogenesis and activates the fak-paxillin pathway for accelerated tissue repair., while Thymosin Alpha-1 complements this by thymic peptide that enhances t-cell maturation, nk cell activity, and cytokine production for comprehensive immune modulation.. Together, they create a comprehensive cellular environment optimized for longevity and resilience.
BPC-157 Targets
Thymosin Alpha-1 Targets
Start This Protocol
Alukard provides physician-supervised longevity protocols, including the BPC-157 + Thymosin Alpha-1 stack, with GMP-certified compounds and comprehensive biomarker testing.
Get Physician ConsultationBegin Your Age Reversal Protocol for BPC-157 + Thymosin Alpha-1 Stack
Alukard provides physician-supervised longevity protocols with GMP-certified compounds, biomarker testing, and personalized biological age reduction programs.
HIPAA Compliant · GMP Certified · Physician Supervised · Biomarker Testing